Search research articles
Contact Us
Filters
Showing results (91-100 of 177) with videos related to
Page
of 18
Sort By:
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections
Jill M Butterfield, Brian T Tsuji, Jack Brown, et al.
Infection Control and Hospital Epidemiology
|
May 8, 2012
The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia
Vanessa Stevens, Thomas P Lodise, Brian Tsuji, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2024
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 9, 2003
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals
Sujata M Bhavnani, Wendy A Callen, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy
|
October 5, 2011
Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia
Christopher M Rubino, Sujata M Bhavnani, Alan Forrest, et al.
Pharmacotherapy
|
May 27, 2015
Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers
Kevin A Kaucher, Nicole M Acquisto, Gauri G Rao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead
Brian T Tsuji, Olanrewaju O Okusanya, Jurgen B Bulitta, et al.
Data in Brief
|
December 21, 2016
Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
Zachary A P Wintrob, Jeffrey P Hammel, George K Nimako, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2005
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi
Brent M Booker, Patrick F Smith, Alan Forrest, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 177) with videos related to
Sort By:
Page
of 18
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections
Jill M Butterfield, Brian T Tsuji, Jack Brown, et al.
Infection Control and Hospital Epidemiology
|
May 8, 2012
The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia
Vanessa Stevens, Thomas P Lodise, Brian Tsuji, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2024
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 9, 2003
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals
Sujata M Bhavnani, Wendy A Callen, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy
|
October 5, 2011
Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia
Christopher M Rubino, Sujata M Bhavnani, Alan Forrest, et al.
Pharmacotherapy
|
May 27, 2015
Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers
Kevin A Kaucher, Nicole M Acquisto, Gauri G Rao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead
Brian T Tsuji, Olanrewaju O Okusanya, Jurgen B Bulitta, et al.
Data in Brief
|
December 21, 2016
Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
Zachary A P Wintrob, Jeffrey P Hammel, George K Nimako, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2005
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi
Brent M Booker, Patrick F Smith, Alan Forrest, et al.
Page
of 18